PTPN1 contributes to the proliferation and metastasis of non-small cell lung cancer (NSCLC) cells by enhancing the Erk1/2 signaling pathway and diminishing the expression of p-Src (Tyr527), which activates Src (43). Here, MAPK3 is linked to non-small cell lung carcinoma.